Four-year incidence and progression of visual impairment in Latinos: the Los Angeles Latino Eye Study.
OBJECTIVE
To determine the 4-year incidence of visual impairment (VI) and blindness and worsening of visual acuity in adult Latinos and Hispanics aged 40 years and older.


METHODS
Population-based, longitudinal study.


METHODS
Participants underwent a detailed ophthalmologic examination including assessing both presenting binocular visual acuity (PVA) and best-corrected distance visual acuity (BCVA) in both eyes using a standard Early Treatment Diabetic Retinopathy protocol. The main outcome measures are 4-year incidence of visual impairment and blindness based on PVA or BCVA in the better-seeing eye and defined as (1) baseline visual acuity (PVA or BCVA) of 20/40 or better and a follow-up PVA or BCVA of less than 20/40 but better than 20/200, and (2) baseline PVA better than 20/200 and a follow-up PVA of 20/200 or less, respectively. Monocular worsening was defined as a decrease of 5 or more, 10, and 15 letters in either eye.


RESULTS
Four thousand six hundred fifty-eight participants were examined at baseline and the 4-year follow-up. The 4-year incidence of presenting binocular VI and blindness was 2.9% and 0.3%. The 4-year incidence of best-corrected VI and blindness was 1.2% and 0.3%. The 4-year incidence of monocular worsening by 5 or more, 10, and 15 letters was 24.8%, 8.5%, and 3.1%, respectively. The incidence of VI and blindness increased with age at baseline (P < .01). The incidence of VI in the second eye (12.2%) was significantly higher than the incidence of VI in the first eye (2.9%; P < .001).


CONCLUSIONS
Overall, the annual incidence of VI in Latinos and Hispanics was higher than that reported in non-Hispanic white persons and the highest reported in a population-based study in the United States. Screening and intervention programs to reduce visual impairment and blindness should focus on the older Latino population.
Varma
Rohit
R
Doheny Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033-9224, USA. rvarma@usc.edu
Chung
Jessica
J
Foong
Athena W P
AW
Torres
Mina
M
Choudhury
Farzana
F
Azen
Stanley P
SP
D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D001766:Blindness / Q000208:ethnology* / Q000503:physiopathology; D018450:Disease Progression; D005260:Female; D006630:Hispanic or Latino / Q000208:ethnology*; D006801:Humans; D015994:Incidence; D008137:Longitudinal Studies; D015141:Los Angeles / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D017678:Sex Distribution; D011795:Surveys and Questionnaires; D014787:Vision Tests; D015348:Vision, Binocular / Q000502:physiology; D014792:Visual Acuity / Q000502:physiology; D019987:Persons with Visual Disabilities / Q000706:statistics & numerical data*
Ophthalmology. 2004 Jan;111(1):118-24
14711723
Ophthalmology. 2003 Jan;110(1):41-50
12511344
Ophthalmology. 1996 Aug;103(8):1169-78
8764783
Ophthalmology. 1996 Mar;103(3):357-64
8600410
Ophthalmology. 1991 Aug;98(8):1310-5
1923372
Clin Exp Ophthalmol. 2003 Oct;31(5):397-402
14516426
J Am Geriatr Soc. 2004 Jul;52(7):1077-84
15209644
Invest Ophthalmol Vis Sci. 1999 Jul;40(8):1645-9
10393030
Am J Ophthalmol. 2006 Oct;142(4):539-49
17011842
Arch Ophthalmol. 1998 May;116(5):653-8
9596502
Ophthalmology. 2006 Oct;113(10):1846-53
16889831
Arch Ophthalmol. 1990 Feb;108(2):286-90
2271016
Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2566-71
12147586
Ophthalmology. 2001 Oct;108(10):1757-66
11581046
Ophthalmology. 2004 Jun;111(6):1121-31
15177962
Ophthalmology. 2003 Jul;110(7):1364-70
12867393
Ophthalmology. 2002 Apr;109(4):737-43
11927431
Ophthalmology. 2004 Jun;111(6):1132-40
15177963
Ophthalmology. 2001 Oct;108(10):1751-6
11581045
Invest Ophthalmol Vis Sci. 1995 Jan;36(1):182-91
7822146